Continuous Glucose Monitoring and PCI

CGM was performed prior and 6 months after PCI. The daily glucose profile was analyzed using data obtained under stabilized conditions on the second and third day to avoid any bias caused by attaching and detaching the CGM sensor. Further, independent investigators blinded to other clinical data calculated the following variables measured using CGM analysis software (CareLink iPro, Medtronic, Northridge, CA): 24-h mean glucose levels, time in hyperglycemia (glucose levels > 140 mg/dl) / hypoglycemia (glucose levels < 70 mg/dl), and the mean amplitude of glycemic excursion (MAGE) [12 (link)]. All patients underwent CGM under nutritionally balanced meals; 25–28 kcal/kg of the ideal body weight, 60% carbohydrate, 15–20% protein, and 20–25% fat [7 (link)].